Nano-X (NNOX) Imaging Slashes Costs As Cash Clock Keeps Ticking

Nano-X Imaging (NNOX) reported a 37% year-over-year revenue increase to $4.2 million for the second quarter, but the company also faced a $40.7 million impairment charge and a nearly halved cash reserve. Growth came from the consolidation of the Nanox Health IT business and a 14% year-over-year increase in teleradiology. The AI and software line added $1 million, with five new installations and pilot programs in the US and India.

Nano-X aims to cut costs by outsourcing chip manufacturing, laying off staff, and relying on third-party partners for manufacturing. The Philadelphia Nanox Imaging Network site began scanning patients and collecting insurance payments, which could generate $500,000 to $1 million annually. However, a $40.7 million impairment charge negatively impacted GAAP gross margin and net loss, and cash reserves dropped from $60 million to $31.4 million.

The restructuring plan, expected to save $2 million annually starting in 2027, will be implemented in stages through 2027.